CALGB-140503: A Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (</=2cm) Peripheral Non-Small Cell Lung Cancer
The purpose of this study is to test a different way of doing surgery for lung cancer in patients who have small tumors with no evidence of spread. Recent studies have questioned whether removing a larger portion of the lung containing the tumor offers much better control of the cancer than removing a smaller section of the lung. The purpose of this clinical trial is to look at whether removal of a small section of lung (called a sublobar resection) is equal to a lobectomy (a larger surgery which takes out an entire section or ‘lobe’ of the lung, or about one-quarter to one-half of one lung, depending on which lobe is taken out). This clinical trial will be studying the overall effects (good and/or bad) of a sublobar resection (smaller segment of your lung) compared to a lobectomy (entire lobe of your lung).
Principal Investigator: Stephen Cattaneo, M.D. (443)- 481-3366
Research Staff: Steven DeMartino, CCRC, CRT, RPFT, AEC (410) 481-4390